Graviti Pharmaceuticals Private Limited 2025-10-29 Health serious FDA
Health · FDA · Recall #FDA-D-0037-2026
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx… Recall
Issued October 29, 2025 · Graviti Pharmaceuticals Private Limited
In October 2025, Graviti Pharmaceuticals Private Limited recalled the Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Tablet/Capsule Specifications
What you should do
- 1 Stop using Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Graviti Pharmaceuticals Private Limited to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Graviti Pharmaceuticals Private Limited
- Category
- Health
- Recall date
- October 29, 2025
- Units affected
- Not reported
- Sold at
- Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.
- Recall number
- FDA-D-0037-2026
- Made in
- India
- Issuing agency
- FDA
In context
- Graviti Pharmaceuticals Private Limited has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.